Suchergebnisse - "Juvekar, Ashish"

PubPharm (8)

1

Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models

enthalten in: Immunotherapy | 2021

von Huarte, E. | Peel, M. | Juvekar, A. | +8

2

Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Huarte, E. | O'Connor, R. | Peel, M. | +9

3

Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment

enthalten in: Clinical immunology (Orlando, Fla.) | 2020

von Yeleswaram, S. | Smith, P. | Burn, T. | +5

4

Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer

enthalten in: Nature cell biology | 2016

von Lien, E. | Lyssiotis, C. | Juvekar, A. | +4

CommentIn: Cell Death Differ. 2016 Aug;23(8):1269-70. - PMID 27315299

5

Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

enthalten in: Cell | 2016

von Hu, H. | Juvekar, A. | Lyssiotis, C. | +15

6

Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer

enthalten in: Cancer discovery | 2012

von Juvekar, A. | Burga, L. | Hu, H. | +14

CommentIn: Nat Rev Cancer. 2012 Oct;12(10):658. - PMID 23001343

7

Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice

enthalten in: Breast cancer research : BCR | 2011

von Burga, L. | Hu, H. | Juvekar, A. | +4

8

Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IkappaBalpha

enthalten in: Archives of biochemistry and biophysics | 2008

von Vu, H. | Juvekar, A. | Ghosh, C. | +3

1
[1]